Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 26, 2025
Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets.
Journal: Hematology/oncology clinics of North America
Published: October 31, 2025
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate.
Journal: Gynecologic oncology
Published: January 27, 2025
Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis.
Journal: Gynecologic oncology
Published: January 21, 2025
Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies.
Journal: JAMA oncology
Published: November 27, 2024
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 21, 2024
Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer.
Journal: Gynecologic oncology
Published: March 18, 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 31, 2024
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Journal: Oncoimmunology
Published: January 03, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results.
Journal: Nature medicine
Published: October 11, 2023
Last Updated: 09/26/2026